What you need to understand is that the only stem cell therapies passed by the the FDA thus far are for hematopoietic, for cancer disorders.
Stem Cell technology will at some time become huge. It has been 30 years in the process and I allowed my professor to take each of my 3 sons ambilocal cords away for stem cell research 20 years ago.
I wouldn't give up on CYP, but you have a long wait, when your money could be doing greater things elsewhere until then.
- Forums
- ASX - By Stock
- CYP
- Ann: Sharewise Investor Presentation
Ann: Sharewise Investor Presentation, page-38
Featured News
Add CYP (ASX) to my watchlist
|
|||||
Last
25.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $44.90M |
Open | High | Low | Value | Volume |
25.0¢ | 25.0¢ | 25.0¢ | $3.097K | 12.38K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 29341 | 25.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
25.5¢ | 11015 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 29341 | 0.250 |
1 | 2500 | 0.245 |
4 | 107225 | 0.240 |
1 | 100000 | 0.235 |
2 | 15173 | 0.230 |
Price($) | Vol. | No. |
---|---|---|
0.270 | 30000 | 1 |
0.280 | 3000 | 1 |
0.290 | 4125 | 2 |
0.295 | 183892 | 1 |
0.300 | 15000 | 1 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
SKS
SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne
CYP (ASX) Chart |